| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Gefitinib | FIMM | pan-cancer | AAC | 0.39 | 0.01 |
| mRNA | KIN001-236 | GDSC1000 | pan-cancer | AAC | 0.089 | 0.01 |
| mRNA | SRT-1720 | CTRPv2 | pan-cancer | AAC | 0.099 | 0.01 |
| mRNA | COL-3 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.01 |
| mRNA | PI-103 | GDSC1000 | pan-cancer | AAC | 0.08 | 0.01 |
| mRNA | KIN001-102 | GDSC1000 | pan-cancer | AAC | 0.077 | 0.01 |
| mRNA | Nilotinib | GDSC1000 | pan-cancer | AAC | -0.096 | 0.01 |
| mRNA | Oxaliplatin | CTRPv2 | pan-cancer | AAC | 0.085 | 0.01 |
| mRNA | Vandetanib | CCLE | pan-cancer | AAC | 0.12 | 0.02 |
| mRNA | ZM-447439 | GDSC1000 | pan-cancer | AAC | 0.093 | 0.02 |